BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20971752)

  • 21. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
    Nakajima T; Kumabe T; Kanamori M; Saito R; Tashiro M; Watanabe M; Tominaga T
    Neurol Med Chir (Tokyo); 2009 Sep; 49(9):394-401. PubMed ID: 19779283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
    Takenaka S; Shinoda J; Asano Y; Aki T; Miwa K; Ito T; Yokoyama K; Iwama T
    Brain Tumor Pathol; 2011 Jul; 28(3):229-38. PubMed ID: 21442242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal imaging in cerebral gliomas and its neuropathological correlation.
    Gempt J; Soehngen E; Förster S; Ryang YM; Schlegel J; Zimmer C; Meyer B; Ringel F; Grams AE; Förschler A
    Eur J Radiol; 2014 May; 83(5):829-34. PubMed ID: 24629350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method.
    Furuya S; Naruse S; Ide M; Morishita H; Kizu O; Ueda S; Maeda T
    NMR Biomed; 1997 Jan; 10(1):25-30. PubMed ID: 9251112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.
    Widhalm G; Kiesel B; Woehrer A; Traub-Weidinger T; Preusser M; Marosi C; Prayer D; Hainfellner JA; Knosp E; Wolfsberger S
    PLoS One; 2013; 8(10):e76988. PubMed ID: 24204718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
    Balmaceda C; Critchell D; Mao X; Cheung K; Pannullo S; DeLaPaz RL; Shungu DC
    J Neurooncol; 2006 Jan; 76(2):185-91. PubMed ID: 16151595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR spectroscopy in gliomatosis cerebri.
    Bendszus M; Warmuth-Metz M; Klein R; Burger R; Schichor C; Tonn JC; Solymosi L
    AJNR Am J Neuroradiol; 2000 Feb; 21(2):375-80. PubMed ID: 10696026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas.
    Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K
    Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
    Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
    Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
    Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
    Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
    Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.
    Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM
    Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.
    Croteau D; Scarpace L; Hearshen D; Gutierrez J; Fisher JL; Rock JP; Mikkelsen T
    Neurosurgery; 2001 Oct; 49(4):823-9. PubMed ID: 11564242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .
    Jeun SS; Kim MC; Kim BS; Lee JM; Chung ST; Oh CH; Lee SY; Choe BY
    Clin Imaging; 2005; 29(1):10-5. PubMed ID: 15859012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2-18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging.
    Stadlbauer A; Prante O; Nimsky C; Salomonowitz E; Buchfelder M; Kuwert T; Linke R; Ganslandt O
    J Nucl Med; 2008 May; 49(5):721-9. PubMed ID: 18413402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.